Uterus contraction medicine study during planned C-sections
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 37 and 41 weeks pregnant
- You are not in labor and have not received oxytocin (a labor-inducing medicine)
- You are having a planned first or second C-section under spinal anesthesia
- You have not had any other uterine surgery or more than one previous C-section
- You do not have placenta accreta (a condition where the placenta grows too deeply into the uterus)
- You are not taking certain medicines like insulin, nifedipine, labetalol, or magnesium sulfate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how three medications (ephedrine, phenylepinephrine, and norepinephrine) affect the contraction strength of uterine muscle tissue from pregnant people with type 2 or gestational diabetes during planned C-sections. It aims to understand if these drugs act differently in people with diabetes, which could help tailor safer treatments for low blood pressure during surgery.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
This trial compares two medication approaches to prevent excessive bleeding during planned cesarean delivery under spinal anesthesia. Researchers want to see if one medication (carbetocin) works as well as carbetocin combined with a second medication (oxytocin).
This trial compares two medications, carbetocin and misoprostol, to see which works better at preventing heavy bleeding (postpartum hemorrhage) after a vaginal delivery. It is for women who have one or more risk factors for heavy bleeding.
This study compares two ways of using misoprostol (a medicine that helps the uterus contract) to prevent heavy bleeding after a C-section. One group gets a vaginal tablet before the surgery, the other gets a tablet under the tongue after the surgery.
This trial tests if giving a medication called misoprostol as a rectal suppository can help reduce bleeding during a planned cesarean section. If you are having a planned cesarean and are generally healthy, this study might be an option for you.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.